Finally a treatment that actually extends survival, if only by...

Finally a treatment that actually extends survival, if only by 3.5 months. The FDA has just approved Torisel from Weyeth. Side effects can be severe. The other two new drugs, Sutent and Nexavar so far have not shown an improvement in survival.

http://sev.prnewswire.com/medical-pharmaceuticals/20070530/NYW15831052007-1.html

The market is still open for an effective RCC drug and that is why I think Coramsines phase 2 for RCC will be the most important clinical trial ever conducted by an Australian Biotech.